Sartorius Stedim Biotech, a key partner to the biopharmaceutical industry, is commemorating the 25th anniversary of its production site in M’Hamdia, Tunisia. The company has maintained a significant presence in Tunisia for a quarter of a century, contributing to the growth of the biopharmaceutical sector. This milestone highlights Sartorius’ long-term commitment to manufacturing in Tunisia and supporting the global biopharma supply chain. The M’Hamdia facility plays a crucial role in the production of biopharmaceutical products. The anniversary underscores the importance of Tunisia as a location for international biopharmaceutical companies. Kapitalis first reported on this significant event for Sartorius and the Tunisian manufacturing landscape.